About this ETF
This ETF is designed to provide investors with a substantial and consistent flow of current income. Its portfolio primarily consists of high-quality, investment-grade corporate debt instruments. The fund targets an average maturity for its bond holdings, weighted by their market value, that typically falls within a range of ten to twenty-five years.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +0.26% | -3.17% | -5.97% | -4.19% | -4.23% | -1.01% | -7.72% | -2.74% | -0.21% |
| Total return | +0.75% | -1.80% | -3.35% | -1.08% | +1.07% | +4.37% | -3.19% | +1.57% | +4.39% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 26, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.03% | Annual cost of a $10,000 investment | $3.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 26, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 2745 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MKTLIQ 12/31/2049 | — | 0.51% | 479.82K | $48.0M |
| 2 | Anheuser-Busch Cos LLC / Anheuser-Busch InBev… | — | 0.37% | 397.22K | $34.7M |
| 3 | CVS Health Corp 5.05% 03/25/2048 | — | 0.33% | 371.97K | $31.4M |
| 4 | Meta Platforms Inc 5.63% 11/15/2055 | — | 0.28% | 312.27K | $26.1M |
| 5 | Boeing Co/The 5.80% 05/01/2050 | — | 0.26% | 254.49K | $24.0M |
| 6 | CVS Health Corp 4.78% 03/25/2038 | — | 0.24% | 244.61K | $22.3M |
| 7 | AT&T Inc 3.55% 09/15/2055 | — | 0.24% | 371.00K | $22.2M |
| 8 | AT&T Inc 3.50% 09/15/2053 | — | 0.23% | 360.78K | $21.8M |
| 9 | Goldman Sachs Group Inc/The 6.75% 10/01/2037 | — | 0.22% | 199.04K | $21.1M |
| 10 | Bank of America Corp 4.08% 03/20/2051 | — | 0.22% | 277.06K | $20.8M |
| 11 | Pfizer Investment Enterprises Pte Ltd 5.30%… | — | 0.22% | 232.13K | $20.8M |
| 12 | Oracle Corp 6.70% 02/04/2056 | — | 0.22% | 233.71K | $20.6M |
| 13 | Amgen Inc 5.65% 03/02/2053 | — | 0.22% | 217.67K | $20.2M |
| 14 | Meta Platforms Inc 5.50% 11/15/2045 | — | 0.21% | 231.63K | $20.1M |
| 15 | Amazon.com Inc 5.80% 03/13/2056 | — | 0.21% | 209.68K | $19.3M |
| 16 | AT&T Inc 3.65% 09/15/2059 | — | 0.20% | 322.70K | $19.1M |
| 17 | AT&T Inc 3.80% 12/01/2057 | — | 0.20% | 306.19K | $18.9M |
| 18 | Meta Platforms Inc 5.75% 11/15/2065 | — | 0.20% | 228.74K | $18.9M |
| 19 | Bank of America Corp 2.68% 06/19/2041 | — | 0.19% | 258.57K | $18.2M |
| 20 | Alphabet Inc 5.45% 11/15/2055 | — | 0.19% | 204.04K | $18.2M |
| 21 | AbbVie Inc 4.05% 11/21/2039 | — | 0.19% | 208.15K | $17.8M |
| 22 | Boeing Co/The 5.93% 05/01/2060 | — | 0.18% | 181.12K | $16.9M |
| 23 | CVS Health Corp 5.13% 07/20/2045 | — | 0.18% | 191.22K | $16.6M |
| 24 | Alphabet Inc 5.65% 02/15/2056 | — | 0.18% | 179.76K | $16.6M |
| 25 | Meta Platforms Inc 6.20% 05/15/2046 | — | 0.17% | 175.27K | $16.5M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 5.62% | Paid (last 12 months) | $4.0813 |
| Frequency | Monthly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Aug 03, 2026 | Last payment | $0.3502 (Aug 05, 2026) |
| Growth 1Y | -1.79% | Growth 3Y / 5Y (ann.) | +4.33% / +4.45% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Aug 03, 2026 | Aug 03, 2026 | Aug 05, 2026 | $0.3502 |
| Jul 01, 2026 | Jul 01, 2026 | Jul 06, 2026 | $0.3422 |
| Jun 01, 2026 | Jun 01, 2026 | Jun 03, 2026 | $0.3551 |
| May 01, 2026 | May 01, 2026 | May 05, 2026 | $0.3274 |
| Apr 01, 2026 | Apr 01, 2026 | Apr 06, 2026 | $0.3561 |
| Mar 02, 2026 | Mar 02, 2026 | Mar 04, 2026 | $0.3181 |
| Feb 02, 2026 | Feb 02, 2026 | Feb 04, 2026 | $0.3456 |
| Dec 18, 2025 | Dec 18, 2025 | Dec 22, 2025 | $0.3492 |
| Dec 01, 2025 | Dec 01, 2025 | Dec 03, 2025 | $0.3402 |
| Nov 03, 2025 | Nov 03, 2025 | Nov 05, 2025 | $0.3334 |
| Oct 01, 2025 | Oct 01, 2025 | Oct 03, 2025 | $0.3292 |
| Sep 02, 2025 | Sep 02, 2025 | Sep 04, 2025 | $0.3346 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 7.97% / 10.68% | Sharpe 1Y / 3Y | -0.29 / 0.12 |
| Max drawdown 1Y / 3Y | -5.86% / -10.25% | Sortino 1Y | -0.405 |
| Beta vs S&P 500 (3Y) | 0.257 | Correlation vs S&P 500 (1Y) | 0.436 |
| Downside deviation 1Y | 5.71% | Risk-free rate used | 3.71% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 27, 2026. Formulas →
Liquidity
| Volume today | 3.63M | Average volume | 4.48M |
| AUM | $9.60B | Premium/Discount | +0.08% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $9.60B → $9.60B |
| 1 Week | -$113.6M | -1.18% | $9.60B → $9.60B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for VCLT
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
VCLT